olomoucine has been researched along with Hormone-Dependent Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hajdúch, M; Hlobilková, A; Kolár, Z; Lenobel, R; Lukesová, M; Mad'arová, J; Murray, PG; Perera, S; Strnad, M; Vojtesek, B | 1 |
1 other study(ies) available for olomoucine and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines.
Topics: Cell Division; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Kinetin; Male; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Purines; Receptors, Androgen; Tumor Cells, Cultured | 2002 |